ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
31.49
+0.71 (2.31%)
Nov 4, 2024, 4:00 PM EST - Market closed
ArriVent BioPharma Employees
ArriVent BioPharma had 40 employees as of December 31, 2023.
Employees
40
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,872,125
Market Cap
1.06B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 40 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Owens & Minor | 22,200 |
| OPKO Health | 3,930 |
| MiMedx Group | 895 |
| Maravai LifeSciences Holdings | 650 |
| Aurinia Pharmaceuticals | 300 |
| Arcutis Biotherapeutics | 296 |
| Evolus | 273 |
| Mesoblast | 73 |
AVBP News
- 2 months ago - ArriVent Announces Positive Proof-Of-Concept Global Phase 1b Interim Data for Firmonertinib Monotherapy In First-Line EGFR PACC Mutant Non-Small Cell Lung Cancer At The 2024 World Conference On Lung Cancer - GlobeNewsWire
- 2 months ago - Aarvik Therapeutics Announces Option Exercise by Collaboration Partner ArriVent BioPharma - Business Wire
- 2 months ago - ArriVent BioPharma Reports Second Quarter 2024 Financial Results - GlobeNewsWire
- 3 months ago - ArriVent to Present Proof-Of-Concept Phase 1b Data for Firmonertinib in EGFR PACC Mutant Non-Small Cell Lung Cancer at the 2024 World Conference on Lung Cancer - GlobeNewsWire
- 5 months ago - ArriVent Announces a Multi-Target ADC Collaboration with Alphamab - GlobeNewsWire
- 6 months ago - ArriVent Appoints John Hohneker, M.D., to its Board of Directors - GlobeNewsWire
- 6 months ago - ArriVent BioPharma Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 7 months ago - ArriVent Appoints Kristine Peterson to its Board of Directors - GlobeNewsWire